🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the safety and side effects of a new positron em...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-09-14
Trial ID
NCT07619599
This phase II trial studies how well pembrolizumab with or without standard...
Status
Terminated
Location
University of California, San Francisco
Start Date
2021-02-09
Trial ID
NCT04370509
Treatments Being Tested
This phase III trial studies how well pembrolizumab works in treating patie...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-03
Trial ID
NCT03244384
The phase II trial tests whether pembrolizumab and dendritic cell-based tre...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2024-10-01
Trial ID
NCT05518032
Treatments Being Tested
This pilot phase II trial studies how well pembrolizumab works in treating ...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2017-02-06
Trial ID
NCT02775851
This randomized phase II trial studies how well pembrolizumab with or witho...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-06-12
Trial ID
NCT03304639
Treatments Being Tested
This phase II trial tests how well pembrolizumab in addition to chemotherap...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-10-01
Trial ID
NCT07275216
This phase III trial compares the effect of immunotherapy (pembrolizumab) p...
Status
Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2024-09-11
Trial ID
NCT06422806
This phase I trial studies the side effects and best dose of pembrolizumab ...
Status
Active Not Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-05-30
Trial ID
NCT03030378
This phase II trial investigates the effect of NBTXR3, radiation therapy, a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-04-07
Trial ID
NCT04862455